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Abstract A pregnancy complicated by typical hemolytic uremic syndrome (HUS) and hemolysis,
elevated liver enzymes, low platelets (HELLP) syndrome is reported. At 20 weeks of
gestation, a case of HUS was diagnosed, with Shiga toxin-producing Escherichia coli
identified. Plasmapheresis allowed continuation of the pregnancy for 5 weeks. Super-
imposed preeclampsia and HELLP syndromewere diagnosed after the establishment of
nephrotic range proteinuria, hypertension and recurrence of hemolysis. This is a
singular case, as it demonstrates that HELLP syndrome can superimpose upon HUS, a
fact that can impact future research on reproductive immunology. It also reminds
clinicians that the overlapping of clinical and laboratory findings in HELLP syndrome
makes the diagnosis of other thrombotic microangiopathies during pregnancy a
clinical challenge.
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Resumo Descreve-se um caso clínico em que às 20 semanas de gestação é diagnosticada
síndrome hemolítica-urêmica com isolamento de Escherichia coli produtora de toxina
Shiga. A terapêutica com plasmaferese permitiu amanutenção da gravidez ao longo de
5 semanas. O surgimento de proteinúria nefrótica, hipertensão e recorrência de
hemólise conduziu ao diagnóstico de sobreposição de pré-eclâmpsia e síndrome
HELLP. Este caso é singular, pois demonstra que a síndrome HELLP pode se sobrepor
a uma síndrome hemolítica-urêmica, um fato que pode influenciar futuras investiga-
ções no âmbito de imunologia reprodutiva. Reforça-se, ainda, que o diagnóstico de
outras microangiopatias trombóticas durante a gestação é um desafio clínico ocasio-
nado pela sobreposição de manifestações clínicas e laboratoriais com a síndrome
HELLP.
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Introduction
Thrombotic microangiopathies are characterized by en-
dothelial cell dysfunction, microvascular thrombosis, plate-
let consumption and reduced tissue perfusion.1,2 As blood
flows through partially constricted microvessels, hemolysis
occurs.2 In pregnancy, its most common form is the hemo-
lysis, elevated liver enzymes, low platelets (HELLP) syn-
drome.1–3 Its pathogenesis is not established, and
hypotheses include alteration in the maternal-fetal immune
balance, or placenta instigated liver-targeted acute inflam-
matory condition, or a severe form of preeclampsia.2 The
microvascular injury in HELLP syndrome is systemic, but
mainly affects the liver.1–3
Hemolytic uremic syndrome (HUS) is another life-threa-
tening thrombotic microangiopathy characterized by hemo-
lytic anemia, thrombocytopenia and acute kidney injury.4
Hypertension can occur due to the activation of the renin-
angiotensin system associated with renal ischemia.4 Shiga
toxin-producing Escherichia coli (STEC) is responsible for the
typical form of the disease.4 It infects humans after the
ingestion of contaminated food or water. Abdominal pain
and hemorrhagic diarrhea develop within 3–7 days, and up
to 10% of the infected patients (usually serotype O157)
develop HUS 4–10 days after the onset of diarrhea. The
microvascular injury is mediated by the Shiga toxin, and
mainly affects the kidney.1,2 Non-STEC-HUS, or atypical
HUS (aHUS), can have multiple etiologies associated
with the dysregulation of the complement activation.2
At the onset, it is difficult to distinguish HUS/aHUS
from thrombotic thrombocytopenic purpura (TTP), a throm-
botic microangiopathy associated with markedly reduced
activity of von Willebrand factor-cleaving metalloprotease
(ADAMTS13).2,4
The authors report a case where both typical HUS and
HELLP syndromes were diagnosed, elucidating the clinical
challenge associated with this differential diagnosis.
Case Presentation
A 42-year-old pregnant patient (after in vitro fertilization),
gravida 3 para 0, without significant medical or surgical
history, was admitted at 20 weeks of gestation for severe
abdominal pain and bloody diarrhea that started after in-
gesting vegetables grown in a family farm. Beside slight
uterine contractions, no other symptoms/signswere present.
On blood tests, only a slight leukocytosis (14,800/mm3) and a
high C-reactive protein (3.3 mg/dl) were noted. Since the
abdominal ultrasound suggested appendicitis, a laparo-
scopic appendectomy was performed. The histological ex-
amination did not confirm the diagnosis. The patient,
asymptomatic, was discharged the next day.
Four days later, she was reevaluated for sudden onset of
peripheral and periorbital edema and oliguria, with normal
blood pressure (BP). Laboratory tests (►Table 1, line1) were
consistent withmicroangiopathic hemolytic anemia, throm-
bocytopenia and acute kidney injury. There was also micro-
scopic hematuria and proteinuria, and amild elevation of the
aspartate aminotransferase (AST) and the alanine amino-
transferase (ALT). Surgical complications were excluded. An
obstetric ultrasound scan excluded signs of fetal distress,
malformations or abnormalities. She was admitted for sus-
pected typical HUS to the intensive care unit (ICU), where
plasmapheresis was immediately started after red blood cell
transfusion. Stool and blood sampleswere negative, but STEC
serotype O157:H7was identified in the urine culture. Plasma
exchange therapywas performed daily for 4 days. Thereafter,
it was performed according to the platelet count and the
lactate dehydrogenase (LDH) level. The replacement fluid
was 100% fresh frozen plasma (FFP) in the first two sessions
and later, 50% albumin solution/50% FFP. Continuous hemo-
diafiltration was performed to avoid fluid overload (the
volume balance was zero during the treatment). Anticoagu-
lationwasperformedwith heparin in the primingof thefilter
and by continuous infusion during the replacement. After an
Table 1 Summary of patient’s blood and urine test results throughout the progression of the disease
Hemogl.
(g/dL)
Platelets
(/mm3)
Creatin.
(mg/dL)
AST/ALT
(UI/I)
LDH
(UI/I)
Haptoglobin
levels
Blood smear Proteinuria
At onset
(20 wks)
7.8 58,000 1.9 85/59 680 undetectable schistocytes Minor degree (þ)
One week after initial plasma
exchange therapy
(21 wks)
9.8 155,000 2.0 36/39 257 normal range - -
After hypertension onset
(23 wks)
8.5 50,000 2.0 37/29 246 undetectable - 7,600 mg/24h
At the threshold of fetal viability
(24 wks)
10.2 73,000 1.5 57/32 620 undetectable schistocytes 14 186 mg/24h
At pulmonary edema onset
(25 wks)
8.9 69,000 1.5 41/71 685 undetectable - -
Two weeks after delivery 8.5 266,000 0.6 16/19 196 normal range normal 187 mg/24h
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; Creatin., creatinine; Hemogl., hemoglobin; LDH, lactate
dehydrogenase; wks, weeks.
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initial worsening of the acute kidney injury (creatinine 2.5
mg/dl, max), the tests started to improve (►Table 1, line 2).
The patient developed hypertension (>160/110 mm Hg)
12 days after admission, requiring diuretic and antihyper-
tensive therapies. The laboratory tests (►Table 1, line 3)were
consistent with the recurrence of hemolysis and thrombo-
cytopenia, mild elevation of transaminases and nephrotic
range proteinuria. Complement activity and complement
proteins were within the normal range, and the auto-anti-
bodies were negative. Later, ADAMTS13 assessment was
normal. Hemolytic uremic syndrome with superimposed
preeclampsia and HELLP syndrome were considered on the
differential diagnosis.
The patient refused to terminate the pregnancy. After the
red blood cell transfusion and hypertension control, the tests
were stable, and she was transferred to a tertiary-care
hospital at 24 weeks of gestation (►Table 1, line 4). A course
of betamethasone was administered for fetal lung maturity.
An ultrasound scan revealed fetal growth restriction with
normal umbilical artery Doppler velocimetry and amniotic
fluid index.
At 25 weeks of gestation, she suffered a sudden relapse of
microangiopathic hemolysis (►Table 1, line 5) and developed
severe hypertension (200/120 mmHg) and acute pulmonary
edema refractory to therapy, suggesting severe preeclampsia
and HELLP syndrome. After discussion with the parents,
delivery of the fetus was decided upon. While on parenteral
magnesium sulfate therapy, an emergency cesarean section
was performed. The neonate (600 g, Apgar scores 4–7-7) was
admitted at the neonatal ICU, but died the next day.
After the delivery, andwithout specific therapy, therewas
remission of the hemolysis, thrombocytopenia, proteinuria
and the renal and hepatic injuries (►Table 1, line 6). The
patient was discharged two weeks later on antihypertensive
therapy, and no further recurrences have been diagnosed.
Discussion
Both HUS and HELLP syndromes are characterized by hemo-
lysis and thrombocytopenia, with or without hypertension
or proteinuria.3–5 Nonetheless, HELLP syndrome is far more
frequent than HUS. Preeclampsia complicates 3–5% of preg-
nancies, and HELLP syndrome develops in 4–14% of women
with severe preeclampsia.2 On the other hand, diagnosis of
HUS/TTP during pregnancy or postpartum is very rare,
probably 1 case in 100,000 pregnancies.1 Furthermore,
STEC-HUS represents only 5–10% of the HUS cases in adults,
compared with > 90% of HUS in children.4
Although both are thrombotic microangiopathies, the
microvascular injury in the HELLP syndrome affects mostly
the liver, while the kidney is the organ most affected in the
HUS.1,2,4,5 Hence, transaminases are significantly elevated in
the HELLP syndrome, but only mildly elevated in the HUS.3–5
In contrast, significant acute kidney injury is infrequently
encountered in patients with HELLP syndrome,2 but it is an
important feature in the clinical course of HUS.1,4
Hemolytic uremic syndrome / thrombotic thrombocyto-
penic purpura should be suspected when hemolysis and
thrombocytopenia are diagnosed during pregnancy in the
presence of a normotensive pregnant woman, or when
associated with hypertension and/or proteinuria before
24 weeks of gestation, or when the renal injury is worse
than the liver injury.1,5 Whenever the patient presents with
hemorrhagic diarrhea, STEC-HUS should be considered .4 In
the case reported, the onset of the disease resembled the
pathophysiology of STEC-HUS, with hemorrhagic diarrhea
preceding hemolytic anemia, thrombocytopenia and acute
kidney injury. In the absence of hypertension and severe liver
injury, and presenting before 24 weeks of gestation, the
diagnosis, although rare, appeared clear. During the diarrheic
period, it is important to keep in mind that increased
leucocyte count in the blood and increased serum C-reactive
protein are risk factors for developing HUS after STEC infec-
tion,4 as occurred in this case.
Plasma exchange is the first line treatment for aHUS.
Conversely, it has no beneficial effect to reduce nephropathy
in STEC-HUS.4 Being difficult to distinguish typical HUS/
aHUS/TTP at the onset, plasmapheresis without delay is
suggested for most adult patients.4While waiting for culture
results, plasmapheresis was, therefore, instituted in our
patient. The isolation of STEC serotype O157:H7 further
corroborated the initial diagnosis, although it was isolated
in the urine but not in the stool culture.
Later development of severe hypertension and nephrotic
range proteinuria, associated with the recurrence of hemo-
lytic anemia and thrombocytopenia, led to an even greater
diagnosis challenge. Within the hypertensive disorders of
pregnancy.3 HELLP syndrome has been categorized as a
complicated form of severe preeclampsia.2 Although hyper-
tension can also occur in the HUS, this usually happens
during the acute phase of the disease, and does not occur
with nephrotic proteinuria.4 Complete remission of the
hemolysis, thrombocytopenia, proteinuria and the renal
and hepatic injuries without a specific therapy after delivery
corroborates the diagnosis of HELLP syndrome.1,2,5 To our
knowledge, there are no other reports of HELLP superim-
posed on HUS.
There are no systematic reviews or randomized trials on
HUS during pregnancy, probably due to its rarity. Stella et al5
reported a series of 14 cases of TTP/HUS in pregnancy or
postpartum encountered in 4 tertiary-care centers over
8 years, which highlights the difficult differential diagnosis
with HELLP. All the patients diagnosed with TTP/HUS before
24 weeks of gestation (n ¼ 6) survived: 3 had term live
births, 1 had a missed abortion, and 2 had intrauterine fetal
death. On the case here reported, the pregnancy was con-
tinued for 5 weeks after the diagnosis of typical HUS, beyond
the threshold of fetal viability. Despite this accomplishment,
unfortunately, the neonate died.
The differential diagnosis also considered unusual HELLP
syndrome postponed by plasma exchange therapy. A few
studies investigated the role of plasma exchange in HELLP
syndrome, and found that it can be an effective treatment for
patients with persistent HELLP syndrome after delivery.6,7
After therapeutic plasma exchange, LDH and AST levels
decrease, and platelets count increases. The mechanism of
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action is still controversial. In theory, plasmapheresis re-
moves from circulation aggregating, procoagulant and va-
soactive factors released from activated platelets and
endothelial cells, leading to renal and hepatic function
improvement.
This case reinforces the difficulty in diagnosing HUS
during pregnancy, considering that several clinical and la-
boratory findings overlap with the far more frequent HELLP
syndrome. Hemolysis, elevated liver enzymes, low platelets
syndrome superimposed upon STEC-HUS is a unique feature
of this case that can impact future research.
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